Listing in pharmacies: which products are authorized since September 2023?

Recently, in September 2023, these regulations underwent significant changes aimed at adapting the French legal framework to European standards, particularly with regard to hyaluronic acid‑based products. These changes reflect a desire to harmonize practices and ensure a safe and relevant product offering for consumers.

New inclusions in the list of authorized products

Two major additions have been made to the list of products that community pharmacists can reference, recommend, and sell:

1. Medical devices for individual use : This category has been expanded to include injectable hyaluronic acid devices. These products, used in particular for aesthetic treatments such as wrinkle filling, are now considered in the same way as other medical devices for individual use, provided they meet the required safety and efficacy standards.

2. Products with no medical purpose : An entirely new category has been created to accommodate injectable hyaluronic acid products with no medical purpose. This regulatory development follows the European Commission's opinion classifying these cosmetic fillers as "implants."

Impact on community pharmacies

These regulatory changes offer community pharmacies the opportunity to expand their product range to include items that meet the growing demand for non‑surgical aesthetic solutions. However, they also require pharmacists to be more vigilant regarding product selection, regulatory compliance, and their suitability for consumer needs and expectations.

SEO Tips

Pharmafield recommends that community pharmacies take a proactive approach to listing these new products. This involves not only complying with strict regulatory and ethical criteria, but also ensuring that these complementary products fit coherently into the pharmacy's overall offering, thus meeting the expectations of an informed and demanding clientele.

The addition of these products to the list of authorized references in pharmacies represents an evolution in the range of solutions available for the well‑being and health of consumers. Pharmacists, key players in public health, are thus entrusted with additional responsibility in advising on and distributing these new solutions, while contributing to the fight against quackery and ensuring rigorous product monitoring.

For more information on the listing and regulation of products in pharmacies, healthcare professionals can consult the documentation made available by the National Order of Pharmacists and the competent health authorities.

Products authorized at the pharmacy

Referencing: which products are authorized in the pharmacy?

The role of training in adapting to new regulations

In the face of these regulatory changes, the importance of continuing education for healthcare professionals cannot be underestimated. Pharmafield, aware of this imperative, is highlighting its training center dedicated to its professionals. Our training modules are specially designed to support pharmacies in the integration of these new product categories, emphasizing regulatory aspects, quality and safety criteria, as well as consulting techniques adapted to these innovations.

We support pharmacists to stay up‑to‑date with the knowledge and skills required in a constantly evolving sector. Our goal is to provide you with all the tools you need to confidently navigate this complex regulatory landscape and continue to provide top‑notch healthcare services to your clients.

To benefit from Pharmafield's expertise, contact us now and get a call back within 90 minutes .